
Think twice before pairing ghee with these foods
Here are a few food options that one should think about twice before pairing with ghee:Honey: Ghee and honey are both packed with health benefits individually. These have anti-inflammatory, antimicrobial, and antioxidant properties that can be great for your health, but moderation is key. Some studies also suggest that mixing the two in equal proportions may lead to the formation of toxic compounds. When the combination is consumed for a prolonged time, it may lead to inflammation.Curd: Curd comes with its own benefits, but pairing it with ghee is generally not recommended. Ghee is warm and oily, whereas curd is cool and heavy. This mismatch may confuse your digestion. It may further lead to bloating, sluggish metabolism, or gut imbalance.Radish: Radish is a winter special that finds a place on the salad plate or as flavourful parathas. Radish and ghee have contrasting tastes and qualities. When taken together in large quantities, they may become too heavy for the digestive system. This combo can lead to indigestion or bloating. However, research is limited on this combination.Citrus fruits: Fruits like oranges, lemons, and amla are great for your health. According to Ayurveda, the acidic nature of citrus fruits can interfere with digestion when combined with ghee which takes more time to digest. This combination has a potential to cause fermentation, gas, or bloating wowing to their contrasting qualities.Ghee may be a powerhouse ingredient, but like most things in life, it works best when used mindfully. Understanding what not to pair it with is just as important as knowing when to include it. For better comprehension of dietary requirements, consulting a professional may help. At the end, consuming things in moderation is of the essence.- Ends

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


India.com
41 minutes ago
- India.com
7 Powerful Benefits Of Sweet Potatoes You Need To Know
Anaika Sohal Jul 25, 2025 They are packed with vitamins A, C, and B6 along with fiber, potassium, and antioxidants. Sweet potatoes help to maintain good vision and protect against age-related eye diseases. It contains antioxidant and vitamin C content that helps to strengthen your immune system naturally. It contains fibre, which helps in healthy digestion and also helps to prevent constipation. It has a low glycemic index which is great for blood sugar control. It contains Vitamin A and antioxidants that help to improve skin texture and fight signs of aging. It contains carbs that offer sustained energy without causing a blood sugar spike. This web story is meant for informational purposes only and must not be considered a substitute for advice provided by qualified medical professionals. Read Next Story


Mint
an hour ago
- Mint
New IPO: NephroPlus files papers with Sebi for ₹353.4 crore IPO to expand Dialysis clinics
Nephrocare Health Services Limited, widely recognized under the brand name NephroPlus, has filed a Draft Red Herring Prospectus (DRHP) with the Securities and Exchange Board of India (SEBI) to raise ₹353.4 crore through an initial public offering (IPO). The Hyderabad-based company plans to use the proceeds to expand its network of dialysis clinics across India and repay outstanding debt, with the balance allocated to general corporate purposes. Advertisement The IPO will include a fresh issue of equity shares worth ₹353.4 crore and an offer-for-sale (OFS) of up to 1.27 crore equity shares by promoter and non-promoter shareholders. Among the OFS participants are Investcorp Private Equity Fund II, Healthcare Parent Limited, Edoras Investment Holdings Pte. Ltd., and 360 One Special Opportunities Fund. The company may also consider a pre-IPO placement of up to ₹70.6 crore, which would reduce the size of the fresh issue accordingly. Asia's Largest Dialysis Service Provider Established in 2009, NephroPlus has emerged as Asia's largest dialysis services provider and the fifth-largest globally in terms of the number of treatments performed in FY25, according to a Frost & Sullivan report. As of now, the company operates 447 clinics across 269 cities in 21 Indian states and 4 Union Territories, serving over 33,000 patients annually. NephroPlus commands more than 50 percent revenue market share in India's organised dialysis services market. Advertisement NephroPlus has also made a significant push into international markets. It currently operates 34 clinics in the Philippines, 5 in Nepal, 4 in Uzbekistan, and recently entered Saudi Arabia in a bid to tap the Middle East healthcare market. The company's promoters include Vikram Vuppala, BVP Trust (Bessemer Venture Partners), and Investcorp-affiliated entities. Proceeds to Fuel Domestic Expansion As per the DRHP, NephroPlus will allocate ₹129.1 crore from the fresh issue proceeds towards setting up new dialysis clinics in India, which aligns with its strategy to grow its domestic footprint. An additional ₹136 crore will be used to pre-pay or repay certain existing borrowings, enhancing the company's financial flexibility and improving its balance sheet. Advertisement In FY25, the company reported ₹755.8 crore in revenue from operations and a profit after tax of ₹67 crore, reflecting robust growth amid increasing demand for kidney care services. With chronic kidney disease (CKD) rising as the third fastest-growing cause of death globally, and diabetes and hypertension being its primary drivers, NephroPlus is well-positioned to benefit from secular health trends. ICICI Securities, Ambit Private Limited, IIFL Capital Services, and Nomura Financial Advisory and Securities (India) are acting as Book Running Lead Managers (BRLMs) for the IPO. Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions. Advertisement


Time of India
2 hours ago
- Time of India
S&R, Saraf guide IHH's Fortis-Gleneagles hospital management tie-up in evolving Indian healthcare market
Advt By , ETLegalWorld Join the community of 2M+ industry professionals. Subscribe to Newsletter to get latest insights & analysis in your inbox. All about ETLegalWorld industry right on your smartphone! Download the ETLegalWorld App and get the Realtime updates and Save your favourite articles. S&R Associates represented Malaysia-headquartered IHH Healthcare Berhad , in the strategic collaboration between its Indian subsidiaries Fortis Healthcare Limited and Gleneagles Healthcare India , pursuant to which Fortis will manage the operations of five hospitals in the Gleneagles India network under an operation and maintenance services agreement. Saraf and Partners advised Fortis on the transaction reflects broader sectoral trends driving India's healthcare M&A activity , which saw deal volumes surge in H1 2025 despite a slight dip in total value. Private players are planning significant bed additions with a capital outlay of approximately INR 32,500 crore over five years, with particular focus on tier-2 and tier-3 city expansion and single-specialty hospitals in oncology, nephrology, and collaboration leverages IHH Healthcare Berhad's global integrated healthcare expertise with Fortis's established Indian market presence, positioning both entities to capitalize on India's expanding healthcare demand. The deal aligns with the domestic hospital sector's leadership in healthcare deal activity, as operators seek operational efficiencies and geographic expansion.S&R Associates' team was led by partners Rajat Sethi and Raya Hazarika, along with associate Stuti Dhundia. Head of competition practice Simran Dhir, partner Akshat Kulshrestha and associates Prerana De, Sehaj Mahajan and Ritik Mohapatra provided competition law advisory. Partner Niti Dixit advised on litigation transaction team led by senior partner Vaibhav Kakkar, partners Sahil Arora and Debarpan Ghosh. Partner Akshayy S Nanda's competition team assisted with regulatory compliance matters.